John R. Murphy - 24 Jan 2023 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role: Director
Signature: /s/ John R. Murphy
Issuer symbol: CVKD
Transactions as of: 24 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 24 Jan 2023, 16:00:41 UTC
Previous filing: 19 Jan 2023
Next filing: 22 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVKD	Common Stock	Conversion of derivative security		+514,792	+1287%		554,792	24 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVKD	Convertible Promissory Note	Conversion of derivative security		-514,792	-100%		0	24 Jan 2023	Common Stock	514,792	$1.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Mr. Murphy was issued 514,792 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $500,000, based on a conversion price of $1.00 per share.